Global Immuno-Oncology Service Supply, Demand and Key Producers, 2024-2030

Page: 113

Published Date: 11 Oct 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Immuno-oncology describes the process of harnessing a patient's own immune system to fight cancer. Over the past decade, immuno-oncology has become an exciting cancer treatment approach due to its specificity, adaptability, and durability. Immuno-oncology services provide a one-stop platform to accelerate immuno-oncology research, including target selection, clinical trials, and monitoring and evaluation services.

The global Immuno-Oncology Service market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Immuno-Oncology Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Immuno-Oncology Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immuno-Oncology Service that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Immuno-Oncology Service total market, 2019-2030, (USD Million)
Global Immuno-Oncology Service total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Immuno-Oncology Service total market, key domestic companies, and share, (USD Million)
Global Immuno-Oncology Service revenue by player, revenue and market share 2019-2024, (USD Million)
Global Immuno-Oncology Service total market by Type, CAGR, 2019-2030, (USD Million)
Global Immuno-Oncology Service total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Immuno-Oncology Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, George Clinical, Laboratory Corporation of America® Holdings, Medpace, Genscript, Shanghai Novamab Biopharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immuno-Oncology Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Immuno-Oncology Service Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Immuno-Oncology Service Market, Segmentation by Type
Basic Research
Clinical Research

Global Immuno-Oncology Service Market, Segmentation by Application:
Pharmaceutical Companies
Medical Device Companies
Other

Companies Profiled:
Crown Bioscience
Bio-Techne
Abcam
WuXi AppTec
Shanghai ChemPartner
George Clinical
Laboratory Corporation of America® Holdings
Medpace
Genscript
Shanghai Novamab Biopharmaceuticals
LIDE
TransCure bioServices

Key Questions Answered
1. How big is the global Immuno-Oncology Service market?
2. What is the demand of the global Immuno-Oncology Service market?
3. What is the year over year growth of the global Immuno-Oncology Service market?
4. What is the total value of the global Immuno-Oncology Service market?
5. Who are the Major Players in the global Immuno-Oncology Service market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Immuno-Oncology Service Introduction
    1.2 World Immuno-Oncology Service Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Immuno-Oncology Service Total Market by Region (by Headquarter Location)
        1.3.1 World Immuno-Oncology Service Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Immuno-Oncology Service Revenue (2019-2030)
        1.3.3 China Based Company Immuno-Oncology Service Revenue (2019-2030)
        1.3.4 Europe Based Company Immuno-Oncology Service Revenue (2019-2030)
        1.3.5 Japan Based Company Immuno-Oncology Service Revenue (2019-2030)
        1.3.6 South Korea Based Company Immuno-Oncology Service Revenue (2019-2030)
        1.3.7 ASEAN Based Company Immuno-Oncology Service Revenue (2019-2030)
        1.3.8 India Based Company Immuno-Oncology Service Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Immuno-Oncology Service Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Immuno-Oncology Service Consumption Value (2019-2030)
    2.2 World Immuno-Oncology Service Consumption Value by Region
        2.2.1 World Immuno-Oncology Service Consumption Value by Region (2019-2024)
        2.2.2 World Immuno-Oncology Service Consumption Value Forecast by Region (2025-2030)
    2.3 United States Immuno-Oncology Service Consumption Value (2019-2030)
    2.4 China Immuno-Oncology Service Consumption Value (2019-2030)
    2.5 Europe Immuno-Oncology Service Consumption Value (2019-2030)
    2.6 Japan Immuno-Oncology Service Consumption Value (2019-2030)
    2.7 South Korea Immuno-Oncology Service Consumption Value (2019-2030)
    2.8 ASEAN Immuno-Oncology Service Consumption Value (2019-2030)
    2.9 India Immuno-Oncology Service Consumption Value (2019-2030)

3 World Immuno-Oncology Service Companies Competitive Analysis
    3.1 World Immuno-Oncology Service Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Immuno-Oncology Service Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Immuno-Oncology Service in 2023
        3.2.3 Global Concentration Ratios (CR8) for Immuno-Oncology Service in 2023
    3.3 Immuno-Oncology Service Company Evaluation Quadrant
    3.4 Immuno-Oncology Service Market: Overall Company Footprint Analysis
        3.4.1 Immuno-Oncology Service Market: Region Footprint
        3.4.2 Immuno-Oncology Service Market: Company Product Type Footprint
        3.4.3 Immuno-Oncology Service Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Immuno-Oncology Service Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Immuno-Oncology Service Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Immuno-Oncology Service Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Immuno-Oncology Service Consumption Value Comparison
        4.2.1 United States VS China: Immuno-Oncology Service Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Immuno-Oncology Service Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Immuno-Oncology Service Companies and Market Share, 2019-2024
        4.3.1 United States Based Immuno-Oncology Service Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Immuno-Oncology Service Revenue, (2019-2024)
    4.4 China Based Companies Immuno-Oncology Service Revenue and Market Share, 2019-2024
        4.4.1 China Based Immuno-Oncology Service Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Immuno-Oncology Service Revenue, (2019-2024)
    4.5 Rest of World Based Immuno-Oncology Service Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Immuno-Oncology Service Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Immuno-Oncology Service Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Immuno-Oncology Service Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Basic Research
        5.2.2 Clinical Research
    5.3 Market Segment by Type
        5.3.1 World Immuno-Oncology Service Market Size by Type (2019-2024)
        5.3.2 World Immuno-Oncology Service Market Size by Type (2025-2030)
        5.3.3 World Immuno-Oncology Service Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Immuno-Oncology Service Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical Companies
        6.2.2 Medical Device Companies
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Immuno-Oncology Service Market Size by Application (2019-2024)
        6.3.2 World Immuno-Oncology Service Market Size by Application (2025-2030)
        6.3.3 World Immuno-Oncology Service Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Crown Bioscience
        7.1.1 Crown Bioscience Details
        7.1.2 Crown Bioscience Major Business
        7.1.3 Crown Bioscience Immuno-Oncology Service Product and Services
        7.1.4 Crown Bioscience Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Crown Bioscience Recent Developments/Updates
        7.1.6 Crown Bioscience Competitive Strengths & Weaknesses
    7.2 Bio-Techne
        7.2.1 Bio-Techne Details
        7.2.2 Bio-Techne Major Business
        7.2.3 Bio-Techne Immuno-Oncology Service Product and Services
        7.2.4 Bio-Techne Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Bio-Techne Recent Developments/Updates
        7.2.6 Bio-Techne Competitive Strengths & Weaknesses
    7.3 Abcam
        7.3.1 Abcam Details
        7.3.2 Abcam Major Business
        7.3.3 Abcam Immuno-Oncology Service Product and Services
        7.3.4 Abcam Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Abcam Recent Developments/Updates
        7.3.6 Abcam Competitive Strengths & Weaknesses
    7.4 WuXi AppTec
        7.4.1 WuXi AppTec Details
        7.4.2 WuXi AppTec Major Business
        7.4.3 WuXi AppTec Immuno-Oncology Service Product and Services
        7.4.4 WuXi AppTec Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 WuXi AppTec Recent Developments/Updates
        7.4.6 WuXi AppTec Competitive Strengths & Weaknesses
    7.5 Shanghai ChemPartner
        7.5.1 Shanghai ChemPartner Details
        7.5.2 Shanghai ChemPartner Major Business
        7.5.3 Shanghai ChemPartner Immuno-Oncology Service Product and Services
        7.5.4 Shanghai ChemPartner Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Shanghai ChemPartner Recent Developments/Updates
        7.5.6 Shanghai ChemPartner Competitive Strengths & Weaknesses
    7.6 George Clinical
        7.6.1 George Clinical Details
        7.6.2 George Clinical Major Business
        7.6.3 George Clinical Immuno-Oncology Service Product and Services
        7.6.4 George Clinical Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 George Clinical Recent Developments/Updates
        7.6.6 George Clinical Competitive Strengths & Weaknesses
    7.7 Laboratory Corporation of America® Holdings
        7.7.1 Laboratory Corporation of America® Holdings Details
        7.7.2 Laboratory Corporation of America® Holdings Major Business
        7.7.3 Laboratory Corporation of America® Holdings Immuno-Oncology Service Product and Services
        7.7.4 Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Laboratory Corporation of America® Holdings Recent Developments/Updates
        7.7.6 Laboratory Corporation of America® Holdings Competitive Strengths & Weaknesses
    7.8 Medpace
        7.8.1 Medpace Details
        7.8.2 Medpace Major Business
        7.8.3 Medpace Immuno-Oncology Service Product and Services
        7.8.4 Medpace Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Medpace Recent Developments/Updates
        7.8.6 Medpace Competitive Strengths & Weaknesses
    7.9 Genscript
        7.9.1 Genscript Details
        7.9.2 Genscript Major Business
        7.9.3 Genscript Immuno-Oncology Service Product and Services
        7.9.4 Genscript Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Genscript Recent Developments/Updates
        7.9.6 Genscript Competitive Strengths & Weaknesses
    7.10 Shanghai Novamab Biopharmaceuticals
        7.10.1 Shanghai Novamab Biopharmaceuticals Details
        7.10.2 Shanghai Novamab Biopharmaceuticals Major Business
        7.10.3 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product and Services
        7.10.4 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Shanghai Novamab Biopharmaceuticals Recent Developments/Updates
        7.10.6 Shanghai Novamab Biopharmaceuticals Competitive Strengths & Weaknesses
    7.11 LIDE
        7.11.1 LIDE Details
        7.11.2 LIDE Major Business
        7.11.3 LIDE Immuno-Oncology Service Product and Services
        7.11.4 LIDE Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 LIDE Recent Developments/Updates
        7.11.6 LIDE Competitive Strengths & Weaknesses
    7.12 TransCure bioServices
        7.12.1 TransCure bioServices Details
        7.12.2 TransCure bioServices Major Business
        7.12.3 TransCure bioServices Immuno-Oncology Service Product and Services
        7.12.4 TransCure bioServices Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 TransCure bioServices Recent Developments/Updates
        7.12.6 TransCure bioServices Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Immuno-Oncology Service Industry Chain
    8.2 Immuno-Oncology Service Upstream Analysis
    8.3 Immuno-Oncology Service Midstream Analysis
    8.4 Immuno-Oncology Service Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Immuno-Oncology Service Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Immuno-Oncology Service Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Immuno-Oncology Service Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Immuno-Oncology Service Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Immuno-Oncology Service Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Immuno-Oncology Service Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Immuno-Oncology Service Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Immuno-Oncology Service Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Immuno-Oncology Service Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Immuno-Oncology Service Players in 2023
 Table 12. World Immuno-Oncology Service Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Immuno-Oncology Service Company Evaluation Quadrant
 Table 14. Head Office of Key Immuno-Oncology Service Players
 Table 15. Immuno-Oncology Service Market: Company Product Type Footprint
 Table 16. Immuno-Oncology Service Market: Company Product Application Footprint
 Table 17. Immuno-Oncology Service Mergers & Acquisitions Activity
 Table 18. United States VS China Immuno-Oncology Service Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Immuno-Oncology Service Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Immuno-Oncology Service Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Immuno-Oncology Service Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Immuno-Oncology Service Revenue Market Share (2019-2024)
 Table 23. China Based Immuno-Oncology Service Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Immuno-Oncology Service Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Immuno-Oncology Service Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Immuno-Oncology Service Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Immuno-Oncology Service Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Immuno-Oncology Service Revenue Market Share (2019-2024)
 Table 29. World Immuno-Oncology Service Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Immuno-Oncology Service Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Immuno-Oncology Service Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Immuno-Oncology Service Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Immuno-Oncology Service Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Immuno-Oncology Service Market Size by Application (2025-2030) & (USD Million)
 Table 35. Crown Bioscience Basic Information, Manufacturing Base and Competitors
 Table 36. Crown Bioscience Major Business
 Table 37. Crown Bioscience Immuno-Oncology Service Product and Services
 Table 38. Crown Bioscience Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Crown Bioscience Recent Developments/Updates
 Table 40. Crown Bioscience Competitive Strengths & Weaknesses
 Table 41. Bio-Techne Basic Information, Manufacturing Base and Competitors
 Table 42. Bio-Techne Major Business
 Table 43. Bio-Techne Immuno-Oncology Service Product and Services
 Table 44. Bio-Techne Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Bio-Techne Recent Developments/Updates
 Table 46. Bio-Techne Competitive Strengths & Weaknesses
 Table 47. Abcam Basic Information, Manufacturing Base and Competitors
 Table 48. Abcam Major Business
 Table 49. Abcam Immuno-Oncology Service Product and Services
 Table 50. Abcam Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Abcam Recent Developments/Updates
 Table 52. Abcam Competitive Strengths & Weaknesses
 Table 53. WuXi AppTec Basic Information, Manufacturing Base and Competitors
 Table 54. WuXi AppTec Major Business
 Table 55. WuXi AppTec Immuno-Oncology Service Product and Services
 Table 56. WuXi AppTec Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. WuXi AppTec Recent Developments/Updates
 Table 58. WuXi AppTec Competitive Strengths & Weaknesses
 Table 59. Shanghai ChemPartner Basic Information, Manufacturing Base and Competitors
 Table 60. Shanghai ChemPartner Major Business
 Table 61. Shanghai ChemPartner Immuno-Oncology Service Product and Services
 Table 62. Shanghai ChemPartner Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Shanghai ChemPartner Recent Developments/Updates
 Table 64. Shanghai ChemPartner Competitive Strengths & Weaknesses
 Table 65. George Clinical Basic Information, Manufacturing Base and Competitors
 Table 66. George Clinical Major Business
 Table 67. George Clinical Immuno-Oncology Service Product and Services
 Table 68. George Clinical Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. George Clinical Recent Developments/Updates
 Table 70. George Clinical Competitive Strengths & Weaknesses
 Table 71. Laboratory Corporation of America® Holdings Basic Information, Manufacturing Base and Competitors
 Table 72. Laboratory Corporation of America® Holdings Major Business
 Table 73. Laboratory Corporation of America® Holdings Immuno-Oncology Service Product and Services
 Table 74. Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Laboratory Corporation of America® Holdings Recent Developments/Updates
 Table 76. Laboratory Corporation of America® Holdings Competitive Strengths & Weaknesses
 Table 77. Medpace Basic Information, Manufacturing Base and Competitors
 Table 78. Medpace Major Business
 Table 79. Medpace Immuno-Oncology Service Product and Services
 Table 80. Medpace Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Medpace Recent Developments/Updates
 Table 82. Medpace Competitive Strengths & Weaknesses
 Table 83. Genscript Basic Information, Manufacturing Base and Competitors
 Table 84. Genscript Major Business
 Table 85. Genscript Immuno-Oncology Service Product and Services
 Table 86. Genscript Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Genscript Recent Developments/Updates
 Table 88. Genscript Competitive Strengths & Weaknesses
 Table 89. Shanghai Novamab Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 90. Shanghai Novamab Biopharmaceuticals Major Business
 Table 91. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product and Services
 Table 92. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Shanghai Novamab Biopharmaceuticals Recent Developments/Updates
 Table 94. Shanghai Novamab Biopharmaceuticals Competitive Strengths & Weaknesses
 Table 95. LIDE Basic Information, Manufacturing Base and Competitors
 Table 96. LIDE Major Business
 Table 97. LIDE Immuno-Oncology Service Product and Services
 Table 98. LIDE Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. LIDE Recent Developments/Updates
 Table 100. LIDE Competitive Strengths & Weaknesses
 Table 101. TransCure bioServices Basic Information, Manufacturing Base and Competitors
 Table 102. TransCure bioServices Major Business
 Table 103. TransCure bioServices Immuno-Oncology Service Product and Services
 Table 104. TransCure bioServices Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. TransCure bioServices Recent Developments/Updates
 Table 106. TransCure bioServices Competitive Strengths & Weaknesses
 Table 107. Global Key Players of Immuno-Oncology Service Upstream (Raw Materials)
 Table 108. Global Immuno-Oncology Service Typical Customers


List of Figures
 Figure 1. Immuno-Oncology Service Picture
 Figure 2. World Immuno-Oncology Service Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Immuno-Oncology Service Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Immuno-Oncology Service Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Immuno-Oncology Service Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Immuno-Oncology Service Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Immuno-Oncology Service Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Immuno-Oncology Service Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Immuno-Oncology Service Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Immuno-Oncology Service Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Immuno-Oncology Service Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Immuno-Oncology Service Revenue (2019-2030) & (USD Million)
 Figure 13. Immuno-Oncology Service Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Immuno-Oncology Service Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Immuno-Oncology Service by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Immuno-Oncology Service Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Immuno-Oncology Service Markets in 2023
 Figure 27. United States VS China: Immuno-Oncology Service Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Immuno-Oncology Service Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Immuno-Oncology Service Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Immuno-Oncology Service Market Size Market Share by Type in 2023
 Figure 31. Basic Research
 Figure 32. Clinical Research
 Figure 33. World Immuno-Oncology Service Market Size Market Share by Type (2019-2030)
 Figure 34. World Immuno-Oncology Service Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Immuno-Oncology Service Market Size Market Share by Application in 2023
 Figure 36. Pharmaceutical Companies
 Figure 37. Medical Device Companies
 Figure 38. Other
 Figure 39. World Immuno-Oncology Service Market Size Market Share by Application (2019-2030)
 Figure 40. Immuno-Oncology Service Industrial Chain
 Figure 41. Methodology
 Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Crown Bioscience
Bio-Techne
Abcam
WuXi AppTec
Shanghai ChemPartner
George Clinical
Laboratory Corporation of America® Holdings
Medpace
Genscript
Shanghai Novamab Biopharmaceuticals
LIDE
TransCure bioServices

Related Reports

Global Immuno-Oncology Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Immuno-Oncology Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 11 Oct 2024

date Service & Software

Product Tags

Immuno-Oncology Service

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>